Skip to main content

MS news

Our news web pages include ground-breaking multiple sclerosis news and research from around the world. 

These news stories are taken from external sources and as such, MS-UK does not verify, endorse or accept responsibility for their content.

Some of these pages have been written for medical professionals and this can be reflected in the complexity of language and content.

Supporting you

We’re here to support you, whether you are awaiting a diagnosis of multiple sclerosis or have been living with the condition for years. 

Find out more about the MS-UK Helpline

Find out more about our Choices booklets

Find out more about New Pathways magazine

 


Recent studies have shown that Tecfidera decreased certain immune cells, of both B-, and T-cell type in MS patients. Studies have also indicated that this class of drugs affects the signalling...
RedHill Biopharma has announced “encouraging” top-line interim results from its CEASE-MS Phase IIa proof-of-concept (PoC) clinical study evaluating fixed oral doses of RHB-104 in patients treated for...
A study claims the molecule neuregulin-1 is indispensable for repairing myelin in models of spinal cord injury, a finding with possibly long-reaching implications for multiple sclerosis treatment....
Lemtrada ‘targets key brain systems’ (31/03/16) A new study published in the Journal of the Neurological Sciences has found Lemtrada affects different aspects of disability to varying degrees. MS...
Biomarkers may predict MS progression (25/02/16) The degree of meningeal inflammation and cortical pathology might prove useful for stratifying patients with early progressive multiple sclerosis (MS...
Government told to restrict Gabapentin and Pregabalin availability (28/01/16) The prescription drugs Gabapentin and Pregabalin could soon be more tightly regulated in the UK, after Government...
MS ‘appears to originate in different part of brain’ (22/12/15) The search for the cause of multiple sclerosis has confounded researchers and medical professionals for generations, but Steven...
Immune-disorder treatment in mice holds potential for MS patients (25/11/15) A University of Florida Health researcher has found a simple way to treat an immune-related disorder in mice, an approach...
Sprinter Cox disqualified for being one minute late (30/10/15) Sprinter Kadeena Cox has been disqualified from the IPC Athletics World Championships after she was one minute late to the call room...
FDA approves electronic autoinjector for MS therapy (28/09/15) The first electronic automatic injector to deliver a drug for the most common form of multiple sclerosis has received approval from the...

Pages